Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation

Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation

Background. Incompatible living donor kidney transplant recipients (ILDKTr) require desensitization to facilitate transplantation, and this substantial upfront immunosuppression may result in serious complications, including cancer. Methods. To characterize cancer risk in ILDKTr, we evaluated 858 IL...

Full description

Bibliographic Details
Main Authors: Jennifer D. Motter, MHS, Allan B. Massie, PhD, Jacqueline M. Garonzik-Wang, MD, PhD, Ruth M. Pfeiffer, PhD, Kelly J. Yu, PhD, Dorry L. Segev, MD, PhD, Eric A. Engels, MD, MPH
Format: Article
Language:English
Published: Wolters Kluwer 2023-08-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001505

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001505

Similar Items